by Werner Siefer, Paul Scherrer Institute Overview of our platform to study the chromatin organization of peripheral blood mononuclear cells in a tumor and proton therapy setting. Credit: npj Precision Oncology (2023). DOI: 10.1038/s41698-023-00484-8 The ability to detect a developing tumor at a very early stage and to closely monitor the success or failure of cancer...
